Free Trial
NASDAQ:EVLO

Evelo Biosciences (EVLO) Stock Price, News & Analysis

Evelo Biosciences logo
$0.0005 0.00 (0.00%)
As of 07/2/2025 02:56 PM Eastern

About Evelo Biosciences Stock (NASDAQ:EVLO)

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
$0.02
Volume
104 shs
Average Volume
13,056 shs
Market Capitalization
$9.49 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

EVLO Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Evelo Biosciences, Inc. (EVLO)
See More Headlines

EVLO Stock Analysis - Frequently Asked Questions

Evelo Biosciences' stock was trading at $0.0005 at the start of the year. Since then, EVLO stock has increased by 0.0% and is now trading at $0.0005.

Evelo Biosciences, Inc. (NASDAQ:EVLO) announced its quarterly earnings data on Wednesday, October, 27th. The company reported ($12.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($10.80) by $1.80.

Evelo Biosciences's stock reverse split before market open on Friday, June 30th 2023.The 1-20 reverse split was announced on Friday, June 30th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Evelo Biosciences (EVLO) raised $85 million in an initial public offering (IPO) on Wednesday, May 9th 2018. The company issued 5,300,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Cowen and BMO Capital Markets served as the underwriters for the IPO and JMP Securities was co-manager.

Shares of EVLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evelo Biosciences investors own include Sangamo Therapeutics (SGMO), Fulcrum Therapeutics (FULC), CymaBay Therapeutics (CBAY), Provention Bio (PRVB), VIVUS (VVUS), Meta Platforms (META) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
10/27/2021
Today
7/05/2025
Next Earnings (Estimated)
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EVLO
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
18,789,000
Market Cap
$9.49 thousand
Optionable
No Data
Beta
0.79
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:EVLO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners